<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39275269</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Comprehensive Analysis of <i>Berberis aristata</i> DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16172953</ELocationID><Abstract><AbstractText>Berberine (BER) is an alkaloid found, together with other protoberberinoids (PROTBERs), in several species used in medicines and food supplements. While some herbal preparations containing BER and PROTBERs, such as <i>Berberis aristata</i> DC. bark extracts, have shown promising potential for human health, their safety has not been fully assessed. Recently, the EFSA issued a call for data to deepen the pharmacokinetic and pharmacodynamic understanding of products containing BER and PROTBERs and to comprehensively assess their safety, especially when used in food supplements. In this context, new data were collected in this work by assessing: (i) the phytochemical profile of 16 different commercial <i>B. aristata</i> dry extracts, which are among the most widely used preparations containing BER and PROTBERs in Europe; (ii) the In Vitro and In Silico investigation of the pharmacokinetic properties of BER and PROTBERs; (iii) the In Vitro cytotoxicity of selected extracts in different human cell lines, including tests on hepatic cells in the presence of CYP450 substrates; (iv) the effects of the extracts on cancer cell migration; and (v) the In Vitro molecular effects of extracts in non-cancer human cells. Results showed that commercial <i>B. aristata</i> extracts contain BER as the main constituent, with jatrorrhizine as main secondary PROTBER. BER and jatrorrhizine were found to have a good bioaccessibility rate, but they interact with P-gp. <i>B. aristata</i> extracts showed limited cytotoxicity and minimal interaction with CYP450 substrates. Furthermore, tested extracts demonstrated inhibition of cancer cell migration and were devoid of any pro-tumoral effects in normal cells. Overall, our work provides a valuable overview to better elucidate important concerns regarding botanicals containing BER and PROTBERs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rigillo</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8853-4431</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappellucci</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0001-2037-3133</Identifier><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0008-0090-2350</Identifier><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miraldi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2130-8624</Identifier><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9273-2839</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, FL 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tascedda</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3422-004X</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorzio Interuniversitario Biotecnologie (CIB), 34148 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Renato</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5992-8722</Identifier><AffiliationInfo><Affiliation>Department of Food and Drug, University of Parma, 43124 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biagi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2997-4178</Identifier><AffiliationInfo><Affiliation>Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food and Drug, University of Parma, 43124 Parma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0I8Y3P32UF</RegistryNumber><NameOfSubstance UI="D001599">Berberine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D028142" MajorTopicYN="Y">Berberis</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="Y">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024301" MajorTopicYN="Y">Plant Bark</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001599" MajorTopicYN="Y">Berberine</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="N">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">berberine</Keyword><Keyword MajorTopicYN="N">bioaccessibility</Keyword><Keyword MajorTopicYN="N">cell viability</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">safety</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39275269</ArticleId><ArticleId IdType="pmc">PMC11397700</ArticleId><ArticleId IdType="doi">10.3390/nu16172953</ArticleId><ArticleId IdType="pii">nu16172953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berberine|C20H18NO4+|CID 2353—PubChem.  [(accessed on 2 January 2024)]; Available online:  https://pubchem.ncbi.nlm.nih.gov/compound/2353.</Citation></Reference><Reference><Citation>Neag M.A., Mocan A., Echeverría J., Pop R.M., Bocsan C.I., Crisan G., Buzoianu A.D. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol. 2018;9:343970. doi: 10.3389/fphar.2018.00557.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00557</ArticleId><ArticleId IdType="pmc">PMC6111450</ArticleId><ArticleId IdType="pubmed">30186157</ArticleId></ArticleIdList></Reference><Reference><Citation>Imenshahidi M., Hosseinzadeh H. Berberine and Barberry (Berberis vulgaris): A Clinical Review. Phytother. Res. 2019;33:504–523. doi: 10.1002/ptr.6252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6252</ArticleId><ArticleId IdType="pubmed">30637820</ArticleId></ArticleIdList></Reference><Reference><Citation>European Pharmacopoeia Commission Press Release—Outcome of the 172nd Session of the European Pharmacopoeia Commission. 2022.  [(accessed on 25 June 2024)].  Available online:  https://www.edqm.eu/en/-/outcome-of-the-172nd-session-of-the-european-pharmacopoeia-commission-march-2022-1.</Citation></Reference><Reference><Citation>Xing L., Zhou X., Li A.H., Li H.J., He C.X., Qin W., Zhao D., Li P.Q., Zhu L., Cao H.L. Atheroprotective Effects and Molecular Mechanism of Berberine. Front. Mol. Biosci. 2021;8:762673. doi: 10.3389/fmolb.2021.762673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.762673</ArticleId><ArticleId IdType="pmc">PMC8636941</ArticleId><ArticleId IdType="pubmed">34869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Zhu W., Zhang X., Zhou X., Wu W., Shen T. Efficacy and Safety of Berberine for Several Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Phytomedicine. 2023;112:154716. doi: 10.1016/j.phymed.2023.154716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.154716</ArticleId><ArticleId IdType="pubmed">36805484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho B.J., Im E.K., Kwon J.H., Lee K.H., Shin H.J., Oh J., Kang S.M., Chung J.H., Jang Y. Berberine Inhibits the Production of Lysophosphatidylcholine-Induced Reactive Oxygen Species and the ERK1/2 Pathway in Vascular Smooth Muscle Cells. Mol. Cells. 2005;20:429–434. doi: 10.1016/S1016-8478(23)13249-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1016-8478(23)13249-3</ArticleId><ArticleId IdType="pubmed">16404160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J., Li J., Lin Q., Xu H. Efficacy and Safety of Berberine for Dyslipidaemias: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Phytomedicine. 2018;50:25–34. doi: 10.1016/j.phymed.2018.09.212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2018.09.212</ArticleId><ArticleId IdType="pubmed">30466986</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Geng Y.-N., Jiang J.-D., Kong W.-J. Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus. Evid. Based Complement. Alternat. Med. 2014;2014:289264. doi: 10.1155/2014/289264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/289264</ArticleId><ArticleId IdType="pmc">PMC3942282</ArticleId><ArticleId IdType="pubmed">24669227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chueh W.H., Lin J.Y. Berberine, an Isoquinoline Alkaloid, Inhibits Streptozotocin-Induced Apoptosis in Mouse Pancreatic Islets through down-Regulating Bax/Bcl-2 Gene Expression Ratio. Food Chem. 2012;132:252–260. doi: 10.1016/j.foodchem.2011.10.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2011.10.065</ArticleId><ArticleId IdType="pubmed">26434288</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Xu X., Yin M., Zhang Y., Huang L., Chen R., Ni J. Effects of Berberine on Blood Glucose in Patients with Type 2 Diabetes Mellitus: A Systematic Literature Review and a Meta-Analysis. Endocr. J. 2019;66:51–63. doi: 10.1507/endocrj.EJ18-0109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ18-0109</ArticleId><ArticleId IdType="pubmed">30393248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C., Su M. Effects of Berberine on Glucose-Lipid Metabolism, Inflammatory Factors and Insulin Resistance in Patients with Metabolic Syndrome. Exp. Ther. Med. 2019;17:3009. doi: 10.3892/etm.2019.7295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7295</ArticleId><ArticleId IdType="pmc">PMC6434235</ArticleId><ArticleId IdType="pubmed">30936971</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazari A., Ghotbabadi Z.R., Kazemi K.S., Metghalchi Y., Tavakoli R., Rahimabadi R.Z., Ghaheri M. The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-Analysis of Randomized Controlled Trials. Clin. Ther. 2023;46:e64–e72. doi: 10.1016/j.clinthera.2023.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2023.10.019</ArticleId><ArticleId IdType="pubmed">38016844</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigrahi A., Mohanty S. Efficacy and Safety of HIMABERB® Berberine on Glycemic Control in Patients with Prediabetes: Double-Blind, Placebo-Controlled, and Randomized Pilot Trial. BMC Endocr. Disord. 2023;23:190. doi: 10.1186/s12902-023-01442-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-023-01442-y</ArticleId><ArticleId IdType="pmc">PMC10483788</ArticleId><ArticleId IdType="pubmed">37679692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Yu Z., Li Y., Fichna J., Storr M. Effects of Berberine in the Gastrointestinal Tract—A Review of Actions and Therapeutic Implications. Am. J. Chin. Med. 2014;42:1053–1070. doi: 10.1142/S0192415X14500669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X14500669</ArticleId><ArticleId IdType="pubmed">25183302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wu X., Yang R., Chen F., Liao Y., Zhu Z., Wu Z., Sun X., Wang L. Effects of Berberine on the Gastrointestinal Microbiota. Front. Cell. Infect. Microbiol. 2020;10:588517. doi: 10.3389/fcimb.2020.588517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.588517</ArticleId><ArticleId IdType="pmc">PMC7933196</ArticleId><ArticleId IdType="pubmed">33680978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu Y., Du X., Ma H., Yao J. The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Manag. Res. 2020;12:695. doi: 10.2147/CMAR.S242329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CMAR.S242329</ArticleId><ArticleId IdType="pmc">PMC6996556</ArticleId><ArticleId IdType="pubmed">32099466</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Tao L., Wang X., Pang Z. Berberine Reversed the Epithelial-Mesenchymal Transition of Normal Colonic Epithelial Cells Induced by SW480 Cells through Regulating the Important Components in the TGF-β Pathway. J. Cell. Physiol. 2019;234:11679–11691. doi: 10.1002/jcp.27835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27835</ArticleId><ArticleId IdType="pubmed">30536375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong C., Hu X., Xu Y., Yang J., Zong L., Wang C., Zhu J., Li Z., Lu D. Berberine Inhibits Proliferation and Migration of Colorectal Cancer Cells by Downregulation of GRP78. Anticancer Drugs. 2020;31:141–149. doi: 10.1097/CAD.0000000000000835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CAD.0000000000000835</ArticleId><ArticleId IdType="pubmed">31743135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertuccioli A., Cardinali M., Biagi M., Moricoli S., Morganti I., Zonzini G.B., Rigillo G. Nutraceuticals and Herbal Food Supplements for Weight Loss: Is There a Prebiotic Role in the Mechanism of Action? Microorganisms. 2021;9:2427. doi: 10.3390/microorganisms9122427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122427</ArticleId><ArticleId IdType="pmc">PMC8703584</ArticleId><ArticleId IdType="pubmed">34946029</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Cai C., Wu X., Fan X., Huang W., Zhou J., Wu Q., Huang Y., Zhao W., Zhang F., et al. An Insight into the Molecular Mechanism of Berberine towards Multiple Cancer Types through Systems Pharmacology. Front. Pharmacol. 2019;10:857. doi: 10.3389/fphar.2019.00857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00857</ArticleId><ArticleId IdType="pmc">PMC6691338</ArticleId><ArticleId IdType="pubmed">31447670</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzka J., Łapińska Z., Szwedowicz U., Gajewska-Naryniecka A., Gizak A., Kulbacka J. Alternations of NF-ΚB Signaling by Natural Compounds in Muscle-Derived Cancers. Int. J. Mol. Sci. 2023;24:11900. doi: 10.3390/ijms241511900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241511900</ArticleId><ArticleId IdType="pmc">PMC10418583</ArticleId><ArticleId IdType="pubmed">37569275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Ma J., Zhang W. Berberine for Bone Regeneration: Therapeutic Potential and Molecular Mechanisms. J. Ethnopharmacol. 2021;277:114249. doi: 10.1016/j.jep.2021.114249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114249</ArticleId><ArticleId IdType="pubmed">34058315</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh J.W., Jun M.S., Yang H.K., Lee B.C. Cellular and Molecular Mechanisms and Effects of Berberine on Obesity-Induced Inflammation. Biomedicines. 2022;10:1739. doi: 10.3390/biomedicines10071739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071739</ArticleId><ArticleId IdType="pmc">PMC9312506</ArticleId><ArticleId IdType="pubmed">35885044</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Chen S.T., Sun Y., Xu Z., Wang Y., Yao S.Y., Yao W.B., Gao X.D. Fibroblast Growth Factor 21 Ameliorates Neurodegeneration in Rat and Cellular Models of Alzheimer’s Disease. Redox Biol. 2019;22:101133. doi: 10.1016/j.redox.2019.101133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101133</ArticleId><ArticleId IdType="pmc">PMC6383137</ArticleId><ArticleId IdType="pubmed">30785085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.K., Chin K.Y., Ima-Nirwana S. Berberine and Musculoskeletal Disorders: The Therapeutic Potential and Underlying Molecular Mechanisms. Phytomedicine. 2020;73:152892. doi: 10.1016/j.phymed.2019.152892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.152892</ArticleId><ArticleId IdType="pubmed">30902523</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Miao Y.Q., Fan D.J., Yang S.S., Lin X., Meng L.K., Tang X. Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats. AAPS PharmSciTech. 2011;12:705–711. doi: 10.1208/s12249-011-9632-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12249-011-9632-z</ArticleId><ArticleId IdType="pmc">PMC3134654</ArticleId><ArticleId IdType="pubmed">21637946</ArticleId></ArticleIdList></Reference><Reference><Citation>He C.Y., Fu J., Shou J.W., Zhao Z.X., Ren L., Wang Y., Jiang J.D. In Vitro Study of the Metabolic Characteristics of Eight Isoquinoline Alkaloids from Natural Plants in Rat Gut Microbiota. Molecules. 2017;22:932. doi: 10.3390/molecules22060932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22060932</ArticleId><ArticleId IdType="pmc">PMC6152661</ArticleId><ArticleId IdType="pubmed">28587219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong F., Chen Y., Chen J., Liao H., Li Y., Ma Y. Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity. Front. Pharmacol. 2022;12:783127. doi: 10.3389/fphar.2021.783127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.783127</ArticleId><ArticleId IdType="pmc">PMC8793695</ArticleId><ArticleId IdType="pubmed">35095493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Yang X.Y., Guo C.E., Bi X.N., Chen J.H., Chen H.Y., Li H.P., Lin H.Y., Zhang Y.J. The Oral Bioavailability, Excretion and Cytochrome P450 Inhibition Properties of Epiberberine: An in Vivo and in Vitro Evaluation. Drug Des. Dev. Ther. 2018;12:57. doi: 10.2147/DDDT.S151660.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S151660</ArticleId><ArticleId IdType="pmc">PMC5749554</ArticleId><ArticleId IdType="pubmed">29343943</ArticleId></ArticleIdList></Reference><Reference><Citation>Basera I.A., Girmeorcid A., Bhatt V.P., Sasteorcid G., Pawarorcid S., Hingoraniorcid L., Shah M.B. Development of Validated UHPLC–PDA with ESI–MS-MS Method for Concurrent Estimation of Magnoflorine, Berbamine, Columbamine, Jatrorrhizine, Palmatine and Berberine in Berberis Aristata. Acta Chromatogr. 2021;34:412–421. doi: 10.1556/1326.2021.00960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/1326.2021.00960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N., Sun R.B., Chen X.L., Zhen L., Ge C., Zhao Y.Q., He J., Geng J.L., Guo J.H., Yu X.Y., et al. In Vitro Assessment of the Glucose-Lowering Effects of Berberrubine-9-O-β-D-Glucuronide, an Active Metabolite of Berberrubine. Acta Pharmacol. Sin. 2017;38:351. doi: 10.1038/aps.2016.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2016.120</ArticleId><ArticleId IdType="pmc">PMC5342660</ArticleId><ArticleId IdType="pubmed">28042874</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W., Jin L., Li L., Wang W., Zeng S., Jiang H., Zhou H. Development and Validation of a HPLC-ESI-MS/MS Method for Simultaneous Quantification of Fourteen Alkaloids in Mouse Plasma after Oral Administration of the Extract of Corydalis yanhusuo Tuber: Application to Pharmacokinetic Study. Molecules. 2018;23:714. doi: 10.3390/molecules23040714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23040714</ArticleId><ArticleId IdType="pmc">PMC6017933</ArticleId><ArticleId IdType="pubmed">29561801</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Pope C., Cheng X., Zhou H., Klaassen C.D. Dose-Response of Berberine on Hepatic Cytochromes P450 MRNA Expression and Activities in Mice. J. Ethnopharmacol. 2011;138:111. doi: 10.1016/j.jep.2011.08.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2011.08.058</ArticleId><ArticleId IdType="pmc">PMC3384737</ArticleId><ArticleId IdType="pubmed">21920422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Shi R., Ma B., Ma Y., Wang C., Wu D., Wang X., Cheng N. CYP450 1A2 and Multiple UGT1A Isoforms Are Responsible for Jatrorrhizine Metabolism in Human Liver Microsomes. Biopharm. Drug Dispos. 2013;34:176–185. doi: 10.1002/bdd.1835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdd.1835</ArticleId><ArticleId IdType="pubmed">23299247</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrba J., Papouskova B., Pyszkova M., Zatloukalova M., Lemr K., Ulrichova J., Vacek J. Metabolism of Palmatine by Human Hepatocytes and Recombinant Cytochromes P450. J. Pharm. Biomed. Anal. 2015;102:193–198. doi: 10.1016/j.jpba.2014.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2014.09.015</ArticleId><ArticleId IdType="pubmed">25285405</ArticleId></ArticleIdList></Reference><Reference><Citation>Call for Data for the Scientific Opinion on the Evaluation of the Safety in Use of Plant Preparations Containing Berberine|EFSA.  [(accessed on 2 January 2024)].  Available online:  https://www.efsa.europa.eu/en/call/call-data-scientific-opinion-evaluation-safety-use-plant-preparations-containing-berberine.</Citation></Reference><Reference><Citation>Governa P., Manetti F., Miraldi E., Biagi M. Effects of in Vitro Simulated Digestion on the Antioxidant Activity of Different Camellia sinensis (L.) Kuntze Leaves Extracts. Eur. Food Res. Technol. 2022;248:119–128. doi: 10.1007/s00217-021-03864-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00217-021-03864-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodkorb A., Egger L., Alminger M., Alvito P., Assunção R., Ballance S., Bohn T., Bourlieu-Lacanal C., Boutrou R., Carrière F., et al. INFOGEST Static in Vitro Simulation of Gastrointestinal Food Digestion. Nat. Protoc. 2019;14:991–1014. doi: 10.1038/s41596-018-0119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-018-0119-1</ArticleId><ArticleId IdType="pubmed">30886367</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina A., Michielin O., Zoete V. SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules OPEN. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42717</ArticleId><ArticleId IdType="pmc">PMC5335600</ArticleId><ArticleId IdType="pubmed">28256516</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran M., Rosen N., Twik M., BarShir R., Stein T.I., Dahary D., Fishilevich S., Lancet D. Practical Guide to Life Science Databases. Springer; Singapore: 2022. The GeneCards Suite; pp. 27–56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-16-5812-9_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Zhou D., Gao L., Zha Y. Prediction of Drug Response in Multilayer Networks Based on Fusion of Multiomics Data. Methods. 2021;192:85–92. doi: 10.1016/j.ymeth.2020.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2020.08.006</ArticleId><ArticleId IdType="pubmed">32798653</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressi G., Rigillo G., Governa P., Borgonetti V., Baini G., Rizzi R., Guarnerio C., Bertaiola O., Frigo M., Merlin M., et al. A Novel Perilla frutescens (L.) Britton Cell-Derived Phytocomplex Regulates Keratinocytes Inflammatory Cascade and Barrier Function and Preserves Vaginal Mucosal Integrity In Vivo. Pharmaceutics. 2023;15:240. doi: 10.3390/pharmaceutics15010240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15010240</ArticleId><ArticleId IdType="pmc">PMC9861994</ArticleId><ArticleId IdType="pubmed">36678869</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressi G., Bertaiola O., Guarnerio C., Barbieri E., Rigillo G., Governa P., Biagi M., Guzzo F., Semenzato A. In Vitro Cell Culture of Rhus coriaria L.: A Standardized Phytocomplex Rich of Gallic Acid Derivatives with Antioxidant and Skin Repair Activity. Cosmetics. 2022;9:12. doi: 10.3390/cosmetics9010012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cosmetics9010012</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigillo G., Ciani M., Benatti C., Blom J.M.C., Tascedda F., Pani L., Alboni S., Brunello N. Vortioxetine Attenuates Neuroinflammation by Modulating the NOD-like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation in Microglia: Implications for Cognitive Function. Neurosci. Appl. 2023;2:103728. doi: 10.1016/j.nsa.2023.103728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nsa.2023.103728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigillo G., Belluti S., Campani V., Ragazzini G., Ronzio M., Miserocchi G., Bighi B., Cuoghi L., Mularoni V., Zappavigna V., et al. The NF-Y Splicing Signature Controls Hybrid EMT and ECM-Related Pathways to Promote Aggressiveness of Colon Cancer. Cancer Lett. 2023;567:216262. doi: 10.1016/j.canlet.2023.216262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2023.216262</ArticleId><ArticleId IdType="pubmed">37307894</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigillo G., Basile V., Belluti S., Ronzio M., Sauta E., Ciarrocchi A., Latella L., Saclier M., Molinari S., Vallarola A., et al. The Transcription Factor NF-Y Participates to Stem Cell Fate Decision and Regeneration in Adult Skeletal Muscle. Nat. Commun. 2021;12:6013. doi: 10.1038/s41467-021-26293-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26293-w</ArticleId><ArticleId IdType="pmc">PMC8516959</ArticleId><ArticleId IdType="pubmed">34650038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciani M., Rigillo G., Benatti C., Pani L., Blom J.M.C., Brunello N., Tascedda F., Alboni S. Time- and Region-Specific Effect of Vortioxetine on Central LPS-Induced Regulation of NLRP3 Inflammasome. Curr. Neuropharmacol. 2024;22:1–13. doi: 10.2174/1570159X22666240705143649.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X22666240705143649</ArticleId><ArticleId IdType="pubmed">39005130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichim M.C., Booker A. Chemical Authentication of Botanical Ingredients: A Review of Commercial Herbal Products. Front. Pharmacol. 2021;12:666850. doi: 10.3389/fphar.2021.666850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.666850</ArticleId><ArticleId IdType="pmc">PMC8082499</ArticleId><ArticleId IdType="pubmed">33935790</ArticleId></ArticleIdList></Reference><Reference><Citation>Danoun S., Balayssac S., Gilard V., Martino R., Malet-Martino M. Quality Evaluation of Berberine Food Supplements with High-Field and Compact 1H NMR Spectrometers. J. Pharm. Biomed. Anal. 2023;223:115161. doi: 10.1016/j.jpba.2022.115161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2022.115161</ArticleId><ArticleId IdType="pubmed">36402125</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharjan B., Payne D.T., Ferrarese I., Giovanna Lupo M., Kumar Shrestha L., Hill J.P., Ariga K., Rossi I., Sharan Shrestha S., Panighel G., et al. Evaluation of the Effects of Natural Isoquinoline Alkaloids on Low Density Lipoprotein Receptor (LDLR) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Hepatocytes, as New Potential Hypocholesterolemic Agents. Bioorg. Chem. 2022;121:105686. doi: 10.1016/j.bioorg.2022.105686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2022.105686</ArticleId><ArticleId IdType="pubmed">35217376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Lim H.J., Park J.H., Lee K.S., Jang Y., Park H.Y. Berberine-Induced LDLR up-Regulation Involves JNK Pathway. Biochem. Biophys. Res. Commun. 2007;362:853–857. doi: 10.1016/j.bbrc.2007.08.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.08.060</ArticleId><ArticleId IdType="pubmed">17767919</ArticleId></ArticleIdList></Reference><Reference><Citation>Katiyar S.K., Meeran S.M., Katiyar N., Akhtar S. P53 Cooperates Berberine-Induced Growth Inhibition and Apoptosis of Non-Small Cell Human Lung Cancer Cells in Vitro and Tumor Xenograft Growth in Vivo. Mol. Carcinog. 2009;48:24–37. doi: 10.1002/mc.20453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20453</ArticleId><ArticleId IdType="pubmed">18459128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu W.H., Hsieh Y.S., Kuo H.C., Teng C.Y., Huang H.I., Wang C.J., Yang S.F., Liou Y.S., Kuo W.H. Berberine Induces Apoptosis in SW620 Human Colonic Carcinoma Cells through Generation of Reactive Oxygen Species and Activation of JNK/P38 MAPK and FasL. Arch. Toxicol. 2007;81:719–728. doi: 10.1007/s00204-006-0169-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-006-0169-y</ArticleId><ArticleId IdType="pubmed">17673978</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z., Kang C., Che S., Su J., Sun Q., Ge T., Guo Y., Lv J., Sun Z., Yang W., et al. Berberine: A Promising Treatment for Neurodegenerative Diseases. Front. Pharmacol. 2022;13:845591. doi: 10.3389/fphar.2022.845591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.845591</ArticleId><ArticleId IdType="pmc">PMC9164284</ArticleId><ArticleId IdType="pubmed">35668943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F.L., Yang Z.H., Liu Y., Li L.X., Liang W.C., Wang X.C., Zhou W.B., Yang Y.H., Hu R.M. Berberine Inhibits the Expression of TNFalpha, MCP-1, and IL-6 in AcLDL-Stimulated Macrophages through PPARgamma Pathway. Endocrine. 2008;33:331–337. doi: 10.1007/s12020-008-9089-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-008-9089-3</ArticleId><ArticleId IdType="pubmed">19034703</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Cao B., Liu X., Fu X., Xiong Z., Chen L., Sartor O., Dong Y., Zhang H. Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer. Mol. Cancer Ther. 2011;10:1346. doi: 10.1158/1535-7163.MCT-10-0985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-10-0985</ArticleId><ArticleId IdType="pmc">PMC3154574</ArticleId><ArticleId IdType="pubmed">21613449</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantová S., čipák L., čerňáková M., Košt‘álová D. Effect of Berberine on Proliferation, Cell Cycle and Apoptosis in HeLa and L1210 Cells. J. Pharm. Pharmacol. 2010;55:1143–1149. doi: 10.1211/002235703322277186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1211/002235703322277186</ArticleId><ArticleId IdType="pubmed">12956905</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Chen M., Wang Z., Fan Q., Lin Z., Tao X., Wu J., Liu Z., Lin R., Zhao C. Berberine Inhibits RA-FLS Cell Proliferation and Adhesion by Regulating RAS/MAPK/FOXO/HIF-1 Signal Pathway in the Treatment of Rheumatoid Arthritis. Bone Jt. Res. 2023;12:91–102. doi: 10.1302/2046-3758.122.BJR-2022-0269.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/2046-3758.122.BJR-2022-0269.R1</ArticleId><ArticleId IdType="pmc">PMC9950669</ArticleId><ArticleId IdType="pubmed">36718649</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Liu F., Jiang S., Liu J., Chen X., Zhang S., Zhao H. Berberine Hydrochloride Inhibits Cell Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer via the Suppression of the MMP2 and Bcl-2/Bax Signaling Pathways. Oncol. Lett. 2018;15:7409. doi: 10.3892/ol.2018.8249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2018.8249</ArticleId><ArticleId IdType="pmc">PMC5920480</ArticleId><ArticleId IdType="pubmed">29725453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo S.N., Wang C.W., Chen Y.S., Huang C.C., Wu T.S., Li L.A., Lee I.J., Ueng Y.F. Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through MiR-21-3p Stimulation in MCF-7 Breast Cancer Cells. Molecules. 2017;22:1847. doi: 10.3390/molecules22111847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22111847</ArticleId><ArticleId IdType="pmc">PMC6150360</ArticleId><ArticleId IdType="pubmed">29143794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W., Yao J.X., Zhang T.T., Wen J.Y., Zhang Z., Luo Y.M., Cao Y., Li H. Network Pharmacology Reveals That Berberine May Function against Alzheimer’s Disease via the AKT Signaling Pathway. Front. Neurosci. 2023;17:1059496. doi: 10.3389/fnins.2023.1059496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1059496</ArticleId><ArticleId IdType="pmc">PMC10192713</ArticleId><ArticleId IdType="pubmed">37214397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Liu S., Wang M., Zhi M., Geng X., Hou C., Wang W., Zhao D. Berberine Restored Nitrergic and Adrenergic Function in Mesenteric and Iliac Arteries from Streptozotocin-Induced Diabetic Rats. J. Ethnopharmacol. 2019;244:112140. doi: 10.1016/j.jep.2019.112140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112140</ArticleId><ArticleId IdType="pubmed">31400506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak S., Luk W.W.K., Cui W., Hu S., Tsim K.W.K., Han Y. Synergistic Inhibition on Acetylcholinesterase by the Combination of Berberine and Palmatine Originally Isolated from Chinese Medicinal Herbs. J. Mol. Neurosci. 2014;53:511–516. doi: 10.1007/s12031-014-0288-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0288-5</ArticleId><ArticleId IdType="pubmed">24793543</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell K.J., Tait S.W.G. Targeting BCL-2 Regulated Apoptosis in Cancer. Open Biol. 2018;8:180002. doi: 10.1098/rsob.180002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180002</ArticleId><ArticleId IdType="pmc">PMC5990650</ArticleId><ArticleId IdType="pubmed">29769323</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian S., Wei Z., Yang W., Huang J., Yang Y., Wang J. The Role of BCL-2 Family Proteins in Regulating Apoptosis and Cancer Therapy. Front. Oncol. 2022;12:985363. doi: 10.3389/fonc.2022.985363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.985363</ArticleId><ArticleId IdType="pmc">PMC9597512</ArticleId><ArticleId IdType="pubmed">36313628</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Letai A., Sarosiek K. Regulation of Apoptosis in Health and Disease: The Balancing Act of BCL-2 Family Proteins. Nat. Rev. Mol. Cell Biol. 2019;20:175–193. doi: 10.1038/s41580-018-0089-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0089-8</ArticleId><ArticleId IdType="pmc">PMC7325303</ArticleId><ArticleId IdType="pubmed">30655609</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Li O., Kan M., Zhang M., Shao D., Pan Y., Zheng H., Zhang X., Chen L., Liu S. Berberine Induces Apoptosis by Suppressing the Arachidonic Acid Metabolic Pathway in Hepatocellular Carcinoma. Mol. Med. Rep. 2015;12:4572–4577. doi: 10.3892/mmr.2015.3926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2015.3926</ArticleId><ArticleId IdType="pubmed">26081696</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma T.V., Lenz L.S., Bottari N.B., Pereira A., Schetinger M.R.C., Morsch V.M., Ulrich H., Pillat M.M., de Andrade C.M. Berberine Induces Apoptosis in Glioblastoma Multiforme U87MG Cells via Oxidative Stress and Independent of AMPK Activity. Mol. Biol. Rep. 2020;47:4393–4400. doi: 10.1007/s11033-020-05500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05500-9</ArticleId><ArticleId IdType="pubmed">32410137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.L., Chou C.C., Yung B.Y.M. Berberine Complexes with DNA in the Berberine-Induced Apoptosis in Human Leukemic HL-60 Cells. Cancer Lett. 1995;93:193–200. doi: 10.1016/0304-3835(95)03809-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3835(95)03809-B</ArticleId><ArticleId IdType="pubmed">7621428</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Liu Q., Xu B., Wu J., Guo C., Zhu F., Yang Q., Gao G., Gong Y., Shao C. Berberine Induces P53-Dependent Cell Cycle Arrest and Apoptosis of Human Osteosarcoma Cells by Inflicting DNA Damage. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 2009;662:75–83. doi: 10.1016/j.mrfmmm.2008.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2008.12.009</ArticleId><ArticleId IdType="pubmed">19159633</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Xu Y., Huang X., Chen Y., Fu J., Xi M., Wang L. Berberine-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species Generation and Mitochondrial-Related Apoptotic Pathway. Tumor Biol. 2015;36:1279–1288. doi: 10.1007/s13277-014-2754-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-014-2754-7</ArticleId><ArticleId IdType="pubmed">25352028</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Fan J., Ai G., Liu J., Luo N., Li C., Cheng Z. Berberine in Combination with Cisplatin Induces Necroptosis and Apoptosis in Ovarian Cancer Cells. Biol. Res. 2019;52:37. doi: 10.1186/s40659-019-0243-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-019-0243-6</ArticleId><ArticleId IdType="pmc">PMC6637630</ArticleId><ArticleId IdType="pubmed">31319879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z., Wan Y., Li B., Zhai C., Yao F., Kang Y., Liu Q., Lin D. Berberine Induces Mitochondrial-Mediated Apoptosis and Protective Autophagy in Human Malignant Pleural Mesothelioma NCI-H2452 Cells. Oncol. Rep. 2018;40:3603–3610. doi: 10.3892/or.2018.6757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2018.6757</ArticleId><ArticleId IdType="pubmed">30272347</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li D., Kuang H., Feng X., Ai W., Wang Y., Shi S., Chen J., Fan R. Berberine Increases Glucose Uptake and Intracellular ROS Levels by Promoting Sirtuin 3 Ubiquitination. Biomed. Pharmacother. 2020;121:109563. doi: 10.1016/j.biopha.2019.109563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109563</ArticleId><ArticleId IdType="pubmed">31706105</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng P.-F., Zhu L.-X., Jie J., Yang P.-X., Chen X. The Intracellular Mechanism of Berberine-Induced Inhibition of CYP3A4 Activity. Curr. Pharm. Des. 2021;27:4179–4185. doi: 10.2174/1381612827666210715155809.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612827666210715155809</ArticleId><ArticleId IdType="pubmed">34269665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian E., Sharma G., Dai C. Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications. Antioxidants. 2023;12:1883. doi: 10.3390/antiox12101883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12101883</ArticleId><ArticleId IdType="pmc">PMC10604532</ArticleId><ArticleId IdType="pubmed">37891961</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q., Ji D., Tian X., Ma L., Sun X. Berberine Inhibits Erastin-Induced Ferroptosis of Mouse Hippocampal Neuronal Cells Possibly by Activating the Nrf2-HO-1/GPX4 Pathway. J. South. Med. Univ. 2022;42:937–943. doi: 10.12122/J.ISSN.1673-4254.2022.06.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.12122/J.ISSN.1673-4254.2022.06.19</ArticleId><ArticleId IdType="pmc">PMC9257364</ArticleId><ArticleId IdType="pubmed">35790446</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Zhou Z. Berberine Inhibits the Proliferation, Invasion and Migration of Endometrial Stromal Cells by Downregulating MiR-429. Mol. Med. Rep. 2021;23:588517. doi: 10.3892/mmr.2021.12055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12055</ArticleId><ArticleId IdType="pmc">PMC8025458</ArticleId><ArticleId IdType="pubmed">33846796</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Qing L., Xu W., Yang Y., You C., Lao Y., Dong Z. Berberine Affects the Proliferation, Migration, Invasion, Cell Cycle, and Apoptosis of Bladder Cancer Cells T24 and 5637 by Down-Regulating the HER2/PI3K/AKT Signaling Pathway. Arch. Esp. Urol. 2023;76:152–160. doi: 10.56434/j.arch.esp.urol.20237602.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.56434/j.arch.esp.urol.20237602.17</ArticleId><ArticleId IdType="pubmed">37139621</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkina V., Rasmussen M.K., Pilipenko N., Zamaratskaia G. Comparison of Xenobiotic-Metabolising Human, Porcine, Rodent, and Piscine Cytochrome P450. Toxicology. 2017;375:10–27. doi: 10.1016/j.tox.2016.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2016.11.014</ArticleId><ArticleId IdType="pubmed">27884721</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Giessrigl B., Vonach C., Madlener S., Prinz S., Herbaceck I., Hölzl C., Bauer S., Viola K., Mikulits W., et al. Berberine and a Berberis Lycium Extract Inactivate Cdc25A and Induce α-Tubulin Acetylation That Correlate with HL-60 Cell Cycle Inhibition and Apoptosis. Mutat. Res./Fundam. Mol. Mech. Mutagen. 2010;683:123–130. doi: 10.1016/j.mrfmmm.2009.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2009.11.001</ArticleId><ArticleId IdType="pubmed">19909759</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.F., Lai K.C., Peng S.F., Maraming P., Huang Y.P., Huang A.C., Chueh F.S., Huang W.W., Chung J.G. Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, UPA, and NF-ΚB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration in Vitro. Molecules. 2018;23:2019. doi: 10.3390/molecules23082019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23082019</ArticleId><ArticleId IdType="pmc">PMC6222729</ArticleId><ArticleId IdType="pubmed">30104528</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L.J., He J.B., Jiang Y., Li J., Zhou Z.W., Zhang C., Tao X., Chen A.F., Peng C., Xie H.H. Berberine Hydrochloride Inhibits Migration Ability via Increasing Inducible NO Synthase and Peroxynitrite in HTR-8/SVneo Cells. J. Ethnopharmacol. 2023;305:116087. doi: 10.1016/j.jep.2022.116087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2022.116087</ArticleId><ArticleId IdType="pubmed">36584918</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarawneh N., Hamadneh L., Abu-Irmaileh B., Shraideh Z., Bustanji Y., Abdalla S. Berberine Inhibited Growth and Migration of Human Colon Cancer Cell Lines by Increasing Phosphatase and Tensin and Inhibiting Aquaporins 1, 3 and 5 Expressions. Molecules. 2023;28:3823. doi: 10.3390/molecules28093823.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28093823</ArticleId><ArticleId IdType="pmc">PMC10180100</ArticleId><ArticleId IdType="pubmed">37175233</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivas U.S., Tan B.W.Q., Vellayappan B.A., Jeyasekharan A.D. ROS and the DNA Damage Response in Cancer. Redox Biol. 2019;25:101084. doi: 10.1016/j.redox.2018.101084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.101084</ArticleId><ArticleId IdType="pmc">PMC6859528</ArticleId><ArticleId IdType="pubmed">30612957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmiento-Salinas F.L., Perez-Gonzalez A., Acosta-Casique A., Ix-Ballote A., Diaz A., Treviño S., Rosas-Murrieta N.H., Millán-Perez-Peña L., Maycotte P. Reactive Oxygen Species: Role in Carcinogenesis, Cancer Cell Signaling and Tumor Progression. Life Sci. 2021;284:119942. doi: 10.1016/j.lfs.2021.119942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119942</ArticleId><ArticleId IdType="pubmed">34506835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassab R.B., Vasicek O., Ciz M., Lojek A., Perecko T. The Effects of Berberine on Reactive Oxygen Species Production in Human Neutrophils and in Cell-Free Assays. Interdiscip. Toxicol. 2017;10:61. doi: 10.1515/intox-2017-0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/intox-2017-0010</ArticleId><ArticleId IdType="pmc">PMC6096855</ArticleId><ArticleId IdType="pubmed">30123039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X.X., Yu X.H., Wang H.D., Yan Y.X., Wang Y.P., Lu D.X., Qi R.B., Hu C.F., Li H.M. Berberine Inhibits Norepinephrine-Induced Apoptosis in Neonatal Rat Cardiomyocytes via Inhibiting ROS-TNF-α-Caspase Signaling Pathway. Chin. J. Integr. Med. 2013;19:424–431. doi: 10.1007/s11655-011-0856-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-011-0856-2</ArticleId><ArticleId IdType="pubmed">22382522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Yuan X., Zhang F., Han Y., Chang X., Xu X., Li Y., Gao X. Berberine Ameliorates Fatty Acid-Induced Oxidative Stress in Human Hepatoma Cells. Sci. Rep. 2017;7:11340. doi: 10.1038/s41598-017-11860-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11860-3</ArticleId><ArticleId IdType="pmc">PMC5595831</ArticleId><ArticleId IdType="pubmed">28900305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S.F., Yasui N., Negishi H., Kishimoto A., Sun J.N., Ikeda K. Increased Oxidative Stress in Cultured 3T3-L1 Cells Was Attenuated by Berberine Treatment. Nat. Prod. Commun. 2015;10:895–897. doi: 10.1177/1934578X1501000626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X1501000626</ArticleId><ArticleId IdType="pubmed">26197511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L., Han Z., Li J., Du Y. C-MYC and HIF1α Promoter G-Quadruplexes Dependent Metabolic Regulation Mechanism of Berberine in Colon Cancer. J. Gastrointest. Oncol. 2022;13:1152–1168. doi: 10.21037/jgo-22-389.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jgo-22-389</ArticleId><ArticleId IdType="pmc">PMC9274050</ArticleId><ArticleId IdType="pubmed">35837174</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauf A., Abu-Izneid T., Khalil A.A., Imran M., Shah Z.A., Bin Emran T., Mitra S., Khan Z., Alhumaydhi F.A., Aljohani A.S.M., et al. Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules. 2021;26:7368. doi: 10.3390/molecules26237368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26237368</ArticleId><ArticleId IdType="pmc">PMC8658774</ArticleId><ArticleId IdType="pubmed">34885950</ArticleId></ArticleIdList></Reference><Reference><Citation>Almatroodi S.A., Alsahli M.A., Rahmani A.H. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules. 2022;27:5889. doi: 10.3390/molecules27185889.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27185889</ArticleId><ArticleId IdType="pmc">PMC9505063</ArticleId><ArticleId IdType="pubmed">36144625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Y., Lu C.-C., Yang J.-S., Chiang J.-H., Li T.-C., Ip S., Hsia T., Liao C., Lin J.-G., Wood W., et al. Berberine Induced Apoptosis via Promoting the Expression of Caspase-8, -9 and -3, Apoptosis-Inducing Factor and Endonuclease G in SCC-4 Human Tongue Squamous Carcinoma Cancer Cells. Anticancer Res. 2009;29:4063–4070.</Citation><ArticleIdList><ArticleId IdType="pubmed">19846952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.-Y., Kim S.-H., Cheong H.-T., Ra C.-S., Rhee K.-J., Jung B.D. Berberine Induces P53-Dependent Apoptosis through Inhibition of DNA Methyltransferase3b in Hep3B Cells. Korean J. Clin. Lab. Sci. 2020;52:69–77. doi: 10.15324/kjcls.2020.52.1.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.15324/kjcls.2020.52.1.69</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>